Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RV4421A BS0042 plus desonide versus desonide alone in adults with atopic dermatitis
2014-002194-10Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Aug 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in atopic dermatitis (AD) comparing RV4421A BS0042 plus desonide with Desonide alone (2 arms). Primary endpoint: L-SCORAD at Day 3. Started Aug 2014; status: completed.
02
Drugs
RV4421A + BS0042desonide
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2014-002194-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002194-10.